OLMA - Olema Pharma says 'falsified information' on social media on breast cancer candidate

Olema Pharmaceurticals (NASDAQ:OLMA) says that there is "falsified information" circulating on social media dealing with a poster presentation on breast cancer candidate OP-1250 at an upcoming medical conference. Trading in the stock was halted at 3:23p ET and did not resume before the market closed. The company will be presenting new data on the phase 1 dose-escalation portion of OP-1250 at the San Antonio Breast Cancer Symposium on Dec. 8. Find out what Jefferies had to say last month about Olema.

For further details see:

Olema Pharma says 'falsified information' on social media on breast cancer candidate